Detect counterfeit pharma raw materials early. Cotecna testing, inspection and audits protect quality, ensure compliance, and reduce supply chain risk.
Rise of Counterfeit and/or Substandard Pharma Raw Materials
Pharmaceutical supply chains are under increasing pressure from globalised sourcing and complex multi-tier supplier networks to tightening regulatory scrutiny and rising risks of fraud. Among the most critical threats is the rise of counterfeit or substandard raw materials. These materials can compromise product safety, disrupt manufacturing, and expose companies to significant regulatory and reputational consequences.
Detecting and mitigating these risks is no longer optional. It is a strategic capability that strengthens supply chain resilience, protects patients, and safeguards brand integrity.
How Counterfeit and Substandard Materials Are a Growing Pharma Risk
Pharmaceutical raw materials, active pharmaceutical ingredients (APIs) and excipients, often pass through multiple intermediaries before reaching manufacturers. This complexity creates vulnerabilities where adulteration, substitution, or misrepresentation can occur.
Common risks include:
- Adulterated APIs diluted or contaminated to cut costs
- Incorrect or substituted excipients with similar appearance but different functionality
- Mislabelled origin or grade, leading to compliance breaches
- Degraded materials due to improper storage or transport
For pharmaceutical manufacturers, the consequences are severe:
- Product recalls and regulatory sanctions
- Manufacturing delays and batch failures
- Patient safety risks
- Long-term brand damage
Detecting these issues early, before materials enter production, is critical to maintaining supply chain integrity.
The Role of Advanced Pharma Testing and Inspection
Comprehensive detection strategies rely on a combination of laboratory testing, verification processes, and supply chain oversight. Together, these measures validate material identity, composition, purity, and compliance with pharmacopeial and regulatory standards.
Key analytical approaches include:
- Identity testing (FTIR, NIR, Raman spectroscopy) to confirm chemical composition
- Chromatographic techniques (HPLC, GC) to detect impurities or adulterants
- Elemental and trace analysis (ICP-OES, ICP-MS) for contamination risks
- Microbiological testing for sterility and microbial limits
- Physical and functional testing to ensure materials perform as intended
However, testing alone is not sufficient. Effective risk mitigation requires integration with inspection, verification, and supplier qualification processes.
How Cotecna Strengthens Pharmaceutical Supply Chains
Cotecna supports pharmaceutical manufacturers, distributors, and procurement teams with a comprehensive suite of Testing, Inspection and Certification (TIC) services designed to detect counterfeit or substandard raw materials before they impact production.
Pharma raw material assurance is very important as it directly impacts product quality, regulatory compliance, and customer trust. By ensuring only genuine and compliant materials enter the production cycle, companies can avoid costly batch failures, delays, and regulatory actions.
More importantly, assurance strengthens client position as high-quality, compliance driven organisations, especially for USFDA and EU-regulated markets. At the same time, protecting patient safety and enhancing long-term brand reputation.
Cotecna Pharma services include:
1.Pharmaceutical Laboratory Testing
Cotecna’s accredited laboratories provide independent, third-party analysis of APIs and excipients to verify:
- Identity and chemical composition
- Purity and impurity profiles
- Compliance with pharmacopeial standards (USP, EP, BP)
- Presence of contaminants or adulterants
Advanced instrumentation and validated methods ensure reliable, defensible results aligned with global regulatory expectations.
2. Incoming Material Verification
Before materials enter production, Cotecna supports incoming quality control processes, helping clients:
- Confirm material specifications against supplier certificates
- Detect discrepancies or inconsistencies in documentation
- Validate batch integrity
This early-stage verification reduces the risk of downstream failures and costly recalls.
3. Supplier and Supply Chain Audits
Counterfeit risks often originate upstream. Cotecna conducts supplier audits and inspections to assess:
- Quality management systems
- Traceability and documentation practices
- Compliance with GMP and regulatory standards
By strengthening supplier due diligence, clients gain greater transparency and control over their sourcing networks.
4. Inspection and Sampling Services
Cotecna provides independent sampling and inspection at key points in the supply chain, including:
- Pre-shipment inspections
- Warehouse and storage condition checks
- Batch sampling under controlled protocols
Independent sampling ensures that materials tested are representative and reduces the risk of tampering or substitution.
Umpire and Dispute Testing
In cases of quality disputes, Cotecna acts as a neutral third party, providing:
- Umpire testing to verify conflicting results
- Independent validation for regulatory or contractual compliance
This supports faster resolution and protects commercial relationships.
Client Benefits: From Risk Mitigation to Operational Confidence
By partnering with Cotecna, pharmaceutical companies can move from reactive quality control to proactive supply chain assurance.
Enhanced Risk Detection
Early identification of counterfeit or substandard materials prevents them from entering production, reducing the likelihood of:
- Batch rejections
- Product recalls
- Regulatory non-compliance
- Stronger Supplier Confidence
Independent audits and verification processes provide greater visibility into supplier performance and reliability.
Regulatory Compliance
Cotecna services align with global regulatory frameworks, supporting adherence to:
- Good Manufacturing Practices (GMP)
- Pharmacopeial standards (USP, EP, BP)
- International quality requirements
Operational Efficiency
By identifying issues early, companies avoid:
- Production downtime
- Wasted materials and resources
- Costly investigations and corrective actions
Brand and Patient Protection
Ultimately, ensuring the quality of raw materials protects both patient safety and brand reputation, reinforcing trust across the value chain.
Building Resilient Pharmaceutical Supply Chains
As pharmaceutical supply chains continue to globalise, the risks associated with counterfeit and substandard raw materials will persist. Detection requires an integrated approach combining testing, verification, inspection, and supply chain intelligence.
Cotecna enables pharmaceutical stakeholders to embed these capabilities into their operations, transforming quality assurance into a strategic advantage.
In a high-stakes industry, certainty is critical. Detecting risks at the source adds strength to supply chains, safeguards patients, and ensures products always meet the highest standards.
Cotecna Global Network
Our network covers over 180 offices and laboratories globally.
Discover Cotecna Pharma Entities
- Neotron
- Shiva Analyticals
- Cotecna Life Sciences
Download the free Cotecna Pharma Services Brochure.
To learn more about Cotecna Pharma Services, or to get a free quote, please contact us.
Follow us on Social Media to keep up with our Adding Strength to Supply Chains series.
About Cotecna
For over 50 years, we have been supporting agriculture, food and pharma, minerals and metals, and consumer products supply chains all over the world. We provide testing, inspection, and certification services to help our clients navigate evolving regulations, ensure product compliance, and support their sustainability journey.